Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth
This invention provides methods for optimal implantation of a solid substrate for promoting cell or tissue growth or restored function in an osteochondral, bone or cartilage tissue in a subject in need thereof. The methods include selecting and preparing a solid substrate for promoting cell or tissue growth or restored function for implantation, which solid substrate has a length and width or that promotes a tight fit within the boundaries of the implantation site and is further characterized by a height sufficient such that when a first terminus of said solid substrate is implanted within a bone in a site for implantation, a second terminus of said solid substrate is at a height at least 2 mm less than an articular cartilage layer surface or is proximal to a tide mark region in said implantation site and optionally applying a biocompatible polymer layer to an apical surface of said implant, which layer does not exceed the articular cartilage layer surface in height. Tools for implementation of optimal positioning are described including a unique tool ( 5 - 120 ) for trimming cartilage at the implantation site.
1. A method for implantation of a solid coralline-based substrate for promoting cell or tissue growth for the treatment of osteoarthritis, bone disorders, osteochondral defects, or cartilage lesions in a subject in need thereof, said method comprising:
selecting and preparing a solid coralline-based substrate for promoting cell or tissue growth for stable implantation in a region traversing bone and cartilage in a subject, which solid coralline-based substrate has a length and width or that fits within the boundaries of the implantation site and is further characterized by a height such that when a first terminus of said solid coralline-based substrate is implanted within bone in a site for implantation, a second terminus of said solid coralline-based substrate is at a height at least 2 mm less than an articular cartilage layer surface or proximal to a tide mark region in said implantation site, wherein said solid coralline-based substrate comprises a coral or coral derivative; and
implanting said selected and prepared solid coralline-based substrate within a site for implantation to span a basal to apical long axis of said site for implantation, wherein a first terminus of said implant is implanted within bone at the basal surface and a second terminus is oriented apically such that said second terminus is at a height at least 2 mm less than an articular cartilage layer surface or is proximal to a tide mark region in said implantation site such that a void is formed between an apical surface of said substrate and an articular cartilage layer to permit cell or tissue growth within the void subsequent to implanting said selected and prepared solid coralline-based substrate within the site; wherein said site of implantation has been prepared for insertion of said solid coralline-based substrate by creating a void of desired dimensions in terms of depth, length and width, and the side walls of the site for implantation have been created to contain a taper, and cartilage tissue within said site for implantation has been removed with the aid of a cartilage cutter, comprising:
an elongated handle;
a head region connected to said elongated handle, said head region further comprising an apical portion which connects with said elongated handle;
a basal portion which inserts within an implantation site, the basal portion having a basal surface that is continuous and substantially flat;
a first and second angled side regions, which taper from said apical portion toward said basal portion;
wherein said first angled side region further comprises:
a tapered blade surface,
a supporting tapered angled surface positioned opposingly to said tapered blade surface; and
a hollowed region located therebetween, whereby tissue in contact with said tapered blade surface cut thereby is of a thickness accommodating insertion within said hollowed region.
2. The method of claim 1 , wherein said solid coralline-based substrate has a height of between 1-20 mm.
3. The method of claim 1 , wherein said solid coralline-based substrate has a diameter of about 1-50 mm.
4. The method of claim 1 , wherein said solid coralline-based substrate is further characterized by tapered sides.
5. The method of claim 4 , wherein said solid coralline-based substrate is further characterized by comprising tapered sides at an angle of from 0.75 to about 4 degrees from a longitudinal axis along said solid coralline-based substrate.
6. The method of claim 5 , wherein said tapered sides are at an angle of about two degrees from a longitudinal axis along said solid coralline-based substrate.
7. The method of claim 1 , wherein said solid coralline-based substrate is characterized by a conical or pyramidal frustum.
8. The method of claim 1 , wherein said solid coralline-based substrate consists essentially of aragonite, calcite, or a combination thereof.
9. The method of claim 8 , wherein said solid coralline-based substrate is characterized by a specific fluid uptake capacity value of at least 75%.
10. The method of claim 9 , wherein said establishing a specific fluid uptake capacity value of said solid coralline-based substrate comprises the step of contacting said solid coralline-based substrate with a fluid for from 0.1-15 minutes, allowing for spontaneous fluid uptake of said fluid within said solid coralline-based substrate to arrive at said spontaneous fluid uptake value.
11. The method of claim 9 , wherein establishing said specific fluid uptake capacity value of said solid coralline-based substrate further comprises the step of contacting said solid coralline-based substrate with a fluid and applying negative pressure to said solid coralline-based substrate to promote maximal uptake of said fluid within said solid coralline-based substrate to arrive at a total fluid uptake value.
12. The method of claim 9 , wherein said fluid is a biologic fluid or a blood analog or a synthetic blood analog.
13. The method of claim 9 , wherein said fluid is water.
14. The method of claim 8 , wherein said solid coralline-based substrate is isolated from enriched coral that has been chemically modified to incorporate silicium into the solid coralline-based substrate.
15. The method of claim 1 , wherein said solid coralline-based substrate comprises a hollow or hollows along a Cartesian coordinate axis of said solid coralline-based substrate.
16. The method of claim 15 , wherein said hollow or hollows are along an axis substantially spanning from said second terminus toward said first terminus.
17. The method of claim 15 , wherein said hollow or hollows are along an axis extending from said second terminus up to half the height of said solid coralline-based substrate, toward said first terminus.
18. The method of claim 15 , wherein said hollow or hollows are along an axis extending from said second terminus up to 30% of the height of said solid coralline-based substrate, toward said first terminus.
19. The method of claim 1 , wherein said solid coralline-based substrate has an overall shape that is ovoid or ellipsoid.
20. The method of claim 1 , wherein said solid coralline-based substrate comprises an oval contour.
21. The method of claim 1 , wherein said implanting is conducted at an implant angle of from about 0.75 to about 4 degrees from an axis perpendicular to the surface of the tissue site being thus treated.
22. The method of claim 21 , wherein said implanting is conducted at an implant angle of from about 2 degrees from an axis perpendicular to the surface of the tissue site being thus treated.
23. The method of claim 1 , wherein said method further comprises the step of contacting said solid coralline-based substrate with cells or tissue or tissue derivatives or blood or blood derivatives pre-operative, intra-operative or post-operative.
24. The method of claim 1 , wherein said solid coralline-based substrate promotes cell or tissue growth in tissue of a subject afflicted with a defect or disorder or disease of the cartilage or bone or a combination thereof.
25. The method of claim 24 , wherein said cartilage defect or disorder or disease comprises a full or partial thickness articular cartilage defect; osteochondral defect;
osteoarthritis, avascular necrosis; osteochondritis dissecans; bone cyst, non-union fractures, fracture, bone defect, bone edema, osteoporosis, a joint defect or a defect resulting from trauma, sports, or repetitive stress.
26. The method of claim 25 , wherein said method serves to delay or eliminate the need for full or partial joint replacement in an affected subject.
27. The method of claim 26 , wherein said method serves to resurface an affected joint in a subject.
28. The method of claim 1 , wherein said method may be accomplished via automated systems for both preparation and implantation of said solid coralline-based substrate.
29. The method of claim 28 , wherein said automated system may make use of robotic systems.
30. The method of claim 1 , wherein said method may provide a customized implant and implantation based on pre-operative imaging and intra-operative findings.
31. The method of claim 1 , further comprising: applying a biocompatible polymer layer or hydrogel or therapeutic compound or cell population or combination thereof, to an apical surface of said implant to fill said void formed between said second terminus and said articular cartilage layer surface.